Streamlining Cancer Research with Molecular Glues

Continuous strides are being made in the quest for effective cancer medications. Current research focuses, amongst other things, on Molecular Glues, otherwise known as MGs. These MGs target specific proteins related to cancer and break them down. Scientists are constantly working to test various MGs for their effectiveness against cancer cells. In recent years, several MGs have already been discovered that can break down certain cancer cells, marking a significant and groundbreaking step in the right direction.

Due to these significant advances, MGs play an essential role in cancer research. A major advantage of MGs over other methods is their molecular size. Compared to other methods, MGs consist of smaller molecules. This often simplifies the design of MGs and reduces the number of molecules they consist of. Consequently, they have a greater chance of being effectively absorbed by the body.

Dispendix hopes to change this by offering an innovative liquid handler: the I.DOT. The I.DOT is designed to minimize time-consuming and repetitive tasks in the laboratory, enabling researchers to accelerate research on MGs. Thanks to the revolutionary design of the I.DOT, dispensing can be done with volumes as small as 2.5 nL, making the device highly suitable for MG research. Additionally, researchers can reduce their sample kit size significantly, resulting in substantial cost savings. The patented ‘Drop Detection’ technology ensures constant monitoring of dispensed droplets, ensuring high accuracy at low volumes.